| Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression G Borsellino, M Kleinewietfeld, D Di Mitri, A Sternjak, A Diamantini, ... Blood, the Journal of the American Society of Hematology 110 (4), 1225-1232, 2007 | 1581 | 2007 |
| Neutrophil diversity and plasticity in tumour progression and therapy S Jaillon, A Ponzetta, D Di Mitri, A Santoni, R Bonecchi, A Mantovani Nature Reviews Cancer 20 (9), 485-503, 2020 | 784 | 2020 |
| Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity A Toso, A Revandkar, D Di Mitri, I Guccini, M Proietti, M Sarti, S Pinton, ... Cell reports 9 (1), 75-89, 2014 | 422 | 2014 |
| Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer D Di Mitri, A Toso, JJ Chen, M Sarti, S Pinton, TR Jost, R D’Antuono, ... Nature 515 (7525), 134-137, 2014 | 369 | 2014 |
| IL-23 secreted by myeloid cells drives castration-resistant prostate cancer A Calcinotto, C Spataro, E Zagato, D Di Mitri, V Gil, M Crespo, ... Nature 559 (7714), 363-369, 2018 | 339 | 2018 |
| Reversible senescence in human CD4+ CD45RA+ CD27− memory T cells D Di Mitri, RI Azevedo, SM Henson, V Libri, NE Riddell, R Macaulay, ... The Journal of Immunology 187 (5), 2093-2100, 2011 | 261 | 2011 |
| Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer J Chen, I Guccini, D Di Mitri, D Brina, A Revandkar, M Sarti, E Pasquini, ... Nature genetics 50 (2), 219-228, 2018 | 186 | 2018 |
| CD49d provides access to “untouched” human Foxp3+ Treg free of contaminating effector cells M Kleinewietfeld, M Starke, D Di Mitri, G Borsellino, L Battistini, ... Blood, The Journal of the American Society of Hematology 113 (4), 827-836, 2009 | 185 | 2009 |
| Re-education of tumor-associated macrophages by CXCR2 blockade drives senescence and tumor inhibition in advanced prostate cancer D Di Mitri, M Mirenda, J Vasilevska, A Calcinotto, N Delaleu, A Revandkar, ... Cell reports 28 (8), 2156-2168. e5, 2019 | 171 | 2019 |
| Cytomegalovirus infection induces the accumulation of short‐lived, multifunctional CD4+ CD45RA+ CD27− T cells: the potential involvement of interleukin‐7 in … V Libri, RI Azevedo, SE Jackson, D Di Mitri, R Lachmann, S Fuhrmann, ... Immunology 132 (3), 326-339, 2011 | 138 | 2011 |
| Characterization of regulatory T cells identified as CD4+CD25highCD39+ in patients with active tuberculosis T Chiacchio, R Casetti, O Butera, V Vanini, S Carrara, E Girardi, D Di Mitri, ... Clinical & Experimental Immunology 156 (3), 463-470, 2009 | 122 | 2009 |
| T regulatory cells are markers of disease activity in multiple sclerosis patients D Dalla Libera, D Di Mitri, A Bergami, D Centonze, C Gasperini, ... PloS one 6 (6), e21386, 2011 | 96 | 2011 |
| Non-cell-autonomous regulation of cellular senescence in cancer D Di Mitri, A Alimonti Trends in cell biology 26 (3), 215-226, 2016 | 93 | 2016 |
| Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer M Masetti, R Carriero, F Portale, G Marelli, N Morina, M Pandini, M Iovino, ... Journal of Experimental Medicine 219 (2), e20210564, 2021 | 79 | 2021 |
| Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target G Alvisi, A Termanini, C Soldani, F Portale, R Carriero, K Pilipow, G Costa, ... Journal of Hepatology 77 (5), 1359-1372, 2022 | 51 | 2022 |
| Molecular pathways: targeting tumor-infiltrating myeloid-derived suppressor cells for cancer therapy D Di Mitri, A Toso, A Alimonti Clinical Cancer Research 21 (14), 3108-3112, 2015 | 47 | 2015 |
| A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours M Kalathur, A Toso, J Chen, A Revandkar, C Danzer-Baltzer, I Guccini, ... Nature communications 6 (1), 7227, 2015 | 45 | 2015 |
| CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes C Camperio, M Muscolini, E Volpe, D Di Mitri, R Mechelli, MC Buscarinu, ... Immunology letters 158 (1-2), 134-142, 2014 | 44 | 2014 |
| Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity A Toso, D Di Mitri, A Alimonti Oncoimmunology 4 (3), e994380, 2015 | 31 | 2015 |
| The p38 mitogen‐activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis D Di Mitri, M Sambucci, M Loiarro, M De Bardi, E Volpe, MT Cencioni, ... Immunology 146 (2), 251-263, 2015 | 29 | 2015 |
